MILLENDO THERAPEUTICS INC's ticker is MLND and the CUSIP is 60040X103. A total of 48 filers reported holding MILLENDO THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,138,000 | -45.7% | 404,930 | -30.7% | 0.02% | -19.0% |
| Q4 2019 | $3,939,000 | +632.2% | 584,457 | +672.4% | 0.02% | +600.0% |
| Q3 2019 | $538,000 | -38.5% | 75,670 | 0.0% | 0.00% | -40.0% |
| Q2 2019 | $875,000 | -22.9% | 75,670 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $1,135,000 | +88.5% | 75,670 | 0.0% | 0.01% | +66.7% |
| Q4 2018 | $602,000 | – | 75,670 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,396,615 | $20,949,000 | 5.04% |
| GREAT POINT PARTNERS LLC | 1,288,093 | $19,321,000 | 1.91% |
| Bpifrance SA | 1,078,670 | $16,180,000 | 1.84% |
| Prosight Management, LP | 270,762 | $4,061,000 | 1.78% |
| NEA Management Company, LLC | 1,766,779 | $26,502,000 | 1.38% |
| ADAMS STREET PARTNERS LLC | 459,146 | $6,543,000 | 1.27% |
| Samsara BioCapital, LLC | 45,101 | $677,000 | 0.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,860 | $925,000 | 0.34% |
| PA Capital LLC | 15,263 | $229,000 | 0.24% |
| Fondren Management LP | 14,478 | $217,000 | 0.17% |